Gullimex attracts investor Holland Capital for further growth
Borne / Amsterdam, 10th of March 2025 – Investment firm Holland Capital is investing in Gullimex, a strong player in measurement, quality, and control solutions within the food and medical sectors. Holland Capital’s investment provides Gullimex the opportunity to realize its growth ambitions.
Growing quality standards
The importance of food safety, patient safety, and hygiene continues to grow in a market characterized by increasingly stringent regulations and rising expectations regarding quality and efficiency. Gullimex supports businesses and institutions in navigating this dynamic and demanding environment, optimizing their processes through its role as an advisor, premium brand supplier, and service partner.
Gullimex ensures consistent quality measurements, optimal hygiene, and safe production within mission-critical processes. The company achieves this through an integrated combination of hardware, software, and services, providing customers with solutions that directly address the specific needs and challenges of the food and medical sectors.
Investment for growth
Gullimex aims to become the leading European provider of measurement, quality, and control solutions, leveraging data to create value for the food and medical industries. With Holland Capital’s investment, the company can achieve its growth ambitions both organically and through strategic acquisitions.
Maarten Snijders, Investment Director AgriFood-Tech at Holland Capital, said: “We are proud to support Gullimex in achieving its ambitions. As an investor with years of experience in Tech, AgriFood, and Healthcare, we aim to contribute to Gullimex’s international growth and its mission to create even more value for all its partners.”
Lucien Kwakkel, CEO of Gullimex, added: “We value Holland Capital as a strategic partner that not only invests in our growth but also actively supports us with expertise, experience, a strong network, and a hands-on mentality. Thanks to their experience and vision, we can further strengthen our position in key markets and accelerate our ambitions both nationally and internationally.”
About Gullimex
Founded in 1981, Gullimex supports a large customer base within the food and medical sectors with measurement and data recording solutions. The team of 60+ experts is active in the fields of food safety, patient safety, and hygiene. Gullimex has offices in the Netherlands, Belgium, and Germany.
About Holland Capital
For over 40 years, Holland Capital has been responsibly and successfully investing in promising Dutch and German SMEs with growth ambitions. The team understands entrepreneurship and strives for an open, sustainable, and professional relationship with the management teams of the companies in which it invests, with the common goal of achieving growth. Holland Capital has offices in Amsterdam and Düsseldorf. With its specialized sector teams, the firm focuses on Healthcare, Technology, and AgriFood-Tech. It understands the dynamics and opportunities within these sectors and has an extensive network.
Holland Venture start nieuw private equity fonds
Amsterdam, 1 juli 2009 - Holland Venture heeft een nieuw private equity fonds van 70 miljoen euro opgezet dat zich richt op groei- en buy-out investeringen in de Benelux. De doelgroep van het fonds bestaat uit bestaande ondernemingen met een ondernemingswaarde tussen...
Verkoop Orthos Europe BV aan Atrium Innovations Inc.
Amsterdam, 22 september 2008 - Holland Venture heeft vandaag haar meerderheidsbelang in Orthos Europe BV verkocht. Orthos Europe BV houdt 100% van de aandelen van AOV Orthomoleculaire Voedingssupplementen BV, een onderneming die hooggedoseerde voedingssupplementen...
Holland Venture verkoopt haar meerderheidsbelang in Sunday’s International aan het management van de onderneming
Amsterdam, 9 juni 2008 - Holland Venture heeft haar meerderheidsbelang in Sunday’s International verkocht aan het management van de onderneming onder leiding van algemeen directeur Rob Bontje. Holland Venture realiseert hiermee een aantrekkelijk rendement op het...
Holland Venture verkoopt haar aandelen in INS Group S.A.
Amsterdam, 12 september 2007 - Holland Venture is verheugd om u te kunnen melden dat zij haar aandelen in INS Group, een in België gevestigd netwerk and systemen integrator, aan BT verkocht heeft. Met BT is overeengekomen dat zij 100% van de aandelen in INS Group...
Vacature Investment Analyst Healthcare BO
Investment Manager buy-out HealthcareInvestment Manager buy-out Healthcare Sector: Private Equity en Venture Capital Locatie: Amsterdam Opleidingsniveau: WO Over onze organisatie Holland Capital is een succesvolle participatiemaatschappij welke zich richt op...
CytoSMART haalt 5,2 miljoen euro op voor productinnovatie en groei
CytoSMART haalt 5,2 miljoen euro op voor productinnovatie en groei Eindhoven, 25 maart 2019 - CytoSMART, de Eindhovense ontwikkelaar en fabrikant van digitale microscopen voor het monitoren van celkweekprocessen, ontvangt een groeifinanciering van 5,2 miljoen euro....
Amsterdam
Krijn Taconiskade 426
1087 HW Amsterdam
+31 (0) 20 3119411
Düsseldorf
Königsallee 42
40212 Düsseldorf
+49 (0) 211 96290120
Contact
info@hollandcapital.nl